nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—KCNH2—Loratadine—atopic dermatitis	0.0446	0.127	CbGbCtD
Sunitinib—CYP3A7—Tacrolimus—atopic dermatitis	0.0312	0.0885	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0312	0.0885	CbGbCtD
Sunitinib—CYP3A5—Tacrolimus—atopic dermatitis	0.0234	0.0664	CbGbCtD
Sunitinib—ABCG2—Hydrocortisone—atopic dermatitis	0.0172	0.0488	CbGbCtD
Sunitinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0153	0.0436	CbGbCtD
Sunitinib—ABCB1—Tacrolimus—atopic dermatitis	0.0152	0.0432	CbGbCtD
Sunitinib—CYP3A7—Hydrocortisone—atopic dermatitis	0.0127	0.036	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0127	0.036	CbGbCtD
Sunitinib—ABCC2—Dexamethasone—atopic dermatitis	0.0118	0.0336	CbGbCtD
Sunitinib—ABCB1—Loratadine—atopic dermatitis	0.0111	0.0316	CbGbCtD
Sunitinib—ABCG2—Dexamethasone—atopic dermatitis	0.0107	0.0304	CbGbCtD
Sunitinib—ABCB1—Methylprednisolone—atopic dermatitis	0.0102	0.0289	CbGbCtD
Sunitinib—CYP3A5—Hydrocortisone—atopic dermatitis	0.00952	0.027	CbGbCtD
Sunitinib—CYP3A4—Tacrolimus—atopic dermatitis	0.00912	0.0259	CbGbCtD
Sunitinib—CYP3A7—Dexamethasone—atopic dermatitis	0.00789	0.0224	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00789	0.0224	CbGbCtD
Sunitinib—CYP3A4—Loratadine—atopic dermatitis	0.00667	0.019	CbGbCtD
Sunitinib—ABCB1—Betamethasone—atopic dermatitis	0.00662	0.0188	CbGbCtD
Sunitinib—ABCB1—Prednisolone—atopic dermatitis	0.00653	0.0186	CbGbCtD
Sunitinib—ABCB1—Hydrocortisone—atopic dermatitis	0.00619	0.0176	CbGbCtD
Sunitinib—ABCB1—Prednisone—atopic dermatitis	0.00617	0.0175	CbGbCtD
Sunitinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0061	0.0173	CbGbCtD
Sunitinib—CYP3A5—Dexamethasone—atopic dermatitis	0.00592	0.0168	CbGbCtD
Sunitinib—CYP3A4—Triamcinolone—atopic dermatitis	0.00462	0.0131	CbGbCtD
Sunitinib—CYP3A4—Betamethasone—atopic dermatitis	0.00397	0.0113	CbGbCtD
Sunitinib—CYP3A4—Prednisolone—atopic dermatitis	0.00392	0.0111	CbGbCtD
Sunitinib—ABCB1—Dexamethasone—atopic dermatitis	0.00385	0.0109	CbGbCtD
Sunitinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00371	0.0105	CbGbCtD
Sunitinib—CYP3A4—Prednisone—atopic dermatitis	0.0037	0.0105	CbGbCtD
Sunitinib—DYRK2—skin of body—atopic dermatitis	0.00348	0.0287	CbGeAlD
Sunitinib—FGFR2—skin epidermis—atopic dermatitis	0.00263	0.0218	CbGeAlD
Sunitinib—CYP3A4—Dexamethasone—atopic dermatitis	0.00231	0.00656	CbGbCtD
Sunitinib—DYRK2—head—atopic dermatitis	0.00227	0.0188	CbGeAlD
Sunitinib—GRK7—head—atopic dermatitis	0.00202	0.0167	CbGeAlD
Sunitinib—CDK16—skin of body—atopic dermatitis	0.00185	0.0153	CbGeAlD
Sunitinib—KIT—skin epidermis—atopic dermatitis	0.00183	0.0151	CbGeAlD
Sunitinib—TLK2—head—atopic dermatitis	0.00172	0.0142	CbGeAlD
Sunitinib—MYLK3—head—atopic dermatitis	0.00166	0.0138	CbGeAlD
Sunitinib—MAP2K1—neck—atopic dermatitis	0.00162	0.0134	CbGeAlD
Sunitinib—CSNK1A1—neck—atopic dermatitis	0.0016	0.0132	CbGeAlD
Sunitinib—CLK1—neck—atopic dermatitis	0.00159	0.0131	CbGeAlD
Sunitinib—BMP2K—neck—atopic dermatitis	0.00156	0.0129	CbGeAlD
Sunitinib—INSR—skin of body—atopic dermatitis	0.0015	0.0124	CbGeAlD
Sunitinib—GRK1—head—atopic dermatitis	0.00146	0.0121	CbGeAlD
Sunitinib—NIM1K—head—atopic dermatitis	0.00146	0.0121	CbGeAlD
Sunitinib—CSNK1G2—skin of body—atopic dermatitis	0.00145	0.012	CbGeAlD
Sunitinib—ERN1—head—atopic dermatitis	0.0014	0.0116	CbGeAlD
Sunitinib—PIP4K2B—head—atopic dermatitis	0.0014	0.0116	CbGeAlD
Sunitinib—TBK1—neck—atopic dermatitis	0.00139	0.0115	CbGeAlD
Sunitinib—MAST1—head—atopic dermatitis	0.00137	0.0114	CbGeAlD
Sunitinib—MYLK—skin of body—atopic dermatitis	0.00136	0.0112	CbGeAlD
Sunitinib—RPS6KB1—neck—atopic dermatitis	0.00133	0.011	CbGeAlD
Sunitinib—RET—neck—atopic dermatitis	0.00133	0.011	CbGeAlD
Sunitinib—DCLK3—head—atopic dermatitis	0.0013	0.0108	CbGeAlD
Sunitinib—STK24—skin of body—atopic dermatitis	0.0013	0.0108	CbGeAlD
Sunitinib—FGFR2—neck—atopic dermatitis	0.00126	0.0104	CbGeAlD
Sunitinib—TYRO3—skin of body—atopic dermatitis	0.00126	0.0104	CbGeAlD
Sunitinib—PAK3—head—atopic dermatitis	0.00121	0.00999	CbGeAlD
Sunitinib—CDK16—head—atopic dermatitis	0.00121	0.00999	CbGeAlD
Sunitinib—RPS6KA5—head—atopic dermatitis	0.00119	0.00985	CbGeAlD
Sunitinib—FLT1—neck—atopic dermatitis	0.00117	0.00966	CbGeAlD
Sunitinib—CLK4—head—atopic dermatitis	0.00115	0.00948	CbGeAlD
Sunitinib—SBK1—head—atopic dermatitis	0.00113	0.00937	CbGeAlD
Sunitinib—PHKG1—head—atopic dermatitis	0.00111	0.00916	CbGeAlD
Sunitinib—DAPK1—head—atopic dermatitis	0.00111	0.00916	CbGeAlD
Sunitinib—BRD4—head—atopic dermatitis	0.00107	0.00887	CbGeAlD
Sunitinib—STK11—head—atopic dermatitis	0.00107	0.00887	CbGeAlD
Sunitinib—RIOK1—head—atopic dermatitis	0.00106	0.00878	CbGeAlD
Sunitinib—MAP2K1—skin of body—atopic dermatitis	0.00105	0.00867	CbGeAlD
Sunitinib—MARK2—head—atopic dermatitis	0.00104	0.00861	CbGeAlD
Sunitinib—CSNK1A1—skin of body—atopic dermatitis	0.00104	0.00856	CbGeAlD
Sunitinib—SGK3—head—atopic dermatitis	0.00103	0.00853	CbGeAlD
Sunitinib—ICK—head—atopic dermatitis	0.00102	0.00845	CbGeAlD
Sunitinib—KDR—neck—atopic dermatitis	0.000987	0.00817	CbGeAlD
Sunitinib—NUAK1—head—atopic dermatitis	0.000987	0.00816	CbGeAlD
Sunitinib—SNRK—head—atopic dermatitis	0.000979	0.0081	CbGeAlD
Sunitinib—INSR—head—atopic dermatitis	0.000979	0.0081	CbGeAlD
Sunitinib—STK38—head—atopic dermatitis	0.000964	0.00797	CbGeAlD
Sunitinib—RPS6KA2—head—atopic dermatitis	0.000964	0.00797	CbGeAlD
Sunitinib—CSNK1E—skin of body—atopic dermatitis	0.000959	0.00793	CbGeAlD
Sunitinib—AURKC—head—atopic dermatitis	0.000956	0.00791	CbGeAlD
Sunitinib—PKN1—head—atopic dermatitis	0.000949	0.00785	CbGeAlD
Sunitinib—CSNK1G2—head—atopic dermatitis	0.000949	0.00785	CbGeAlD
Sunitinib—PRPF4—head—atopic dermatitis	0.000935	0.00773	CbGeAlD
Sunitinib—MAP2K2—skin of body—atopic dermatitis	0.000923	0.00764	CbGeAlD
Sunitinib—PRPF4B—head—atopic dermatitis	0.000922	0.00762	CbGeAlD
Sunitinib—STK39—head—atopic dermatitis	0.000909	0.00752	CbGeAlD
Sunitinib—CSNK2A1—head—atopic dermatitis	0.000897	0.00742	CbGeAlD
Sunitinib—TYK2—skin of body—atopic dermatitis	0.000892	0.00737	CbGeAlD
Sunitinib—MYLK—head—atopic dermatitis	0.000885	0.00732	CbGeAlD
Sunitinib—KIT—neck—atopic dermatitis	0.000875	0.00724	CbGeAlD
Sunitinib—STK4—head—atopic dermatitis	0.000869	0.00719	CbGeAlD
Sunitinib—AXL—skin of body—atopic dermatitis	0.000855	0.00707	CbGeAlD
Sunitinib—PDGFRB—neck—atopic dermatitis	0.000855	0.00707	CbGeAlD
Sunitinib—PHKG2—head—atopic dermatitis	0.000854	0.00706	CbGeAlD
Sunitinib—STK24—head—atopic dermatitis	0.000849	0.00702	CbGeAlD
Sunitinib—STK16—head—atopic dermatitis	0.000826	0.00683	CbGeAlD
Sunitinib—HIPK2—head—atopic dermatitis	0.000821	0.00679	CbGeAlD
Sunitinib—TYRO3—head—atopic dermatitis	0.000821	0.00679	CbGeAlD
Sunitinib—ALK—head—atopic dermatitis	0.000821	0.00679	CbGeAlD
Sunitinib—FGFR2—skin of body—atopic dermatitis	0.000816	0.00674	CbGeAlD
Sunitinib—RIOK2—head—atopic dermatitis	0.000813	0.00672	CbGeAlD
Sunitinib—JAK2—skin of body—atopic dermatitis	0.000811	0.00671	CbGeAlD
Sunitinib—MAP3K19—head—atopic dermatitis	0.000805	0.00666	CbGeAlD
Sunitinib—FYN—skin of body—atopic dermatitis	0.0008	0.00662	CbGeAlD
Sunitinib—DAPK3—head—atopic dermatitis	0.000789	0.00653	CbGeAlD
Sunitinib—MAP3K3—skin of body—atopic dermatitis	0.000782	0.00647	CbGeAlD
Sunitinib—CLK2—head—atopic dermatitis	0.000782	0.00647	CbGeAlD
Sunitinib—STK3—head—atopic dermatitis	0.000768	0.00635	CbGeAlD
Sunitinib—ROCK1—head—atopic dermatitis	0.000758	0.00627	CbGeAlD
Sunitinib—EPHB6—skin of body—atopic dermatitis	0.000747	0.00618	CbGeAlD
Sunitinib—DYRK1A—head—atopic dermatitis	0.000739	0.00611	CbGeAlD
Sunitinib—MERTK—head—atopic dermatitis	0.000722	0.00597	CbGeAlD
Sunitinib—MAP4K4—head—atopic dermatitis	0.000709	0.00586	CbGeAlD
Sunitinib—MAP3K12—head—atopic dermatitis	0.000698	0.00578	CbGeAlD
Sunitinib—RPS6KA3—head—atopic dermatitis	0.000689	0.0057	CbGeAlD
Sunitinib—MAP2K1—head—atopic dermatitis	0.000684	0.00566	CbGeAlD
Sunitinib—CSNK1A1—head—atopic dermatitis	0.000675	0.00559	CbGeAlD
Sunitinib—CLK1—head—atopic dermatitis	0.000671	0.00555	CbGeAlD
Sunitinib—CAMK2G—head—atopic dermatitis	0.000659	0.00545	CbGeAlD
Sunitinib—BMP2K—head—atopic dermatitis	0.000659	0.00545	CbGeAlD
Sunitinib—LRRK2—head—atopic dermatitis	0.000653	0.0054	CbGeAlD
Sunitinib—PRKAA1—head—atopic dermatitis	0.000643	0.00532	CbGeAlD
Sunitinib—PTK2B—head—atopic dermatitis	0.000636	0.00526	CbGeAlD
Sunitinib—FLT4—head—atopic dermatitis	0.000634	0.00525	CbGeAlD
Sunitinib—CSNK1E—head—atopic dermatitis	0.000626	0.00518	CbGeAlD
Sunitinib—CSF1R—skin of body—atopic dermatitis	0.000624	0.00516	CbGeAlD
Sunitinib—IRAK4—head—atopic dermatitis	0.000616	0.0051	CbGeAlD
Sunitinib—MAP2K2—head—atopic dermatitis	0.000602	0.00498	CbGeAlD
Sunitinib—ULK3—head—atopic dermatitis	0.000602	0.00498	CbGeAlD
Sunitinib—MAP3K2—head—atopic dermatitis	0.000598	0.00495	CbGeAlD
Sunitinib—TBK1—head—atopic dermatitis	0.000586	0.00484	CbGeAlD
Sunitinib—TYK2—head—atopic dermatitis	0.000582	0.00481	CbGeAlD
Sunitinib—KIT—skin of body—atopic dermatitis	0.000566	0.00468	CbGeAlD
Sunitinib—RPS6KB1—head—atopic dermatitis	0.000563	0.00466	CbGeAlD
Sunitinib—RPS6KA1—Temsirolimus—Tacrolimus—atopic dermatitis	0.000562	0.0882	CbGdCrCtD
Sunitinib—RPS6KA1—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000562	0.0882	CbGdCrCtD
Sunitinib—RPS6KA1—Sirolimus—Pimecrolimus—atopic dermatitis	0.000562	0.0882	CbGdCrCtD
Sunitinib—RPS6KA1—Sirolimus—Tacrolimus—atopic dermatitis	0.000562	0.0882	CbGdCrCtD
Sunitinib—RET—head—atopic dermatitis	0.00056	0.00463	CbGeAlD
Sunitinib—FGR—head—atopic dermatitis	0.00056	0.00463	CbGeAlD
Sunitinib—AXL—head—atopic dermatitis	0.000558	0.00461	CbGeAlD
Sunitinib—PDGFRB—skin of body—atopic dermatitis	0.000553	0.00457	CbGeAlD
Sunitinib—FGFR2—head—atopic dermatitis	0.000532	0.0044	CbGeAlD
Sunitinib—JAK2—head—atopic dermatitis	0.000529	0.00438	CbGeAlD
Sunitinib—FYN—head—atopic dermatitis	0.000522	0.00432	CbGeAlD
Sunitinib—MAP3K3—head—atopic dermatitis	0.00051	0.00422	CbGeAlD
Sunitinib—MAP4K5—head—atopic dermatitis	0.00051	0.00422	CbGeAlD
Sunitinib—FLT1—head—atopic dermatitis	0.000493	0.00408	CbGeAlD
Sunitinib—EPHB6—head—atopic dermatitis	0.000488	0.00403	CbGeAlD
Sunitinib—YES1—head—atopic dermatitis	0.000471	0.0039	CbGeAlD
Sunitinib—STK10—head—atopic dermatitis	0.000467	0.00386	CbGeAlD
Sunitinib—TAOK3—head—atopic dermatitis	0.000465	0.00385	CbGeAlD
Sunitinib—PDGFRA—head—atopic dermatitis	0.000462	0.00382	CbGeAlD
Sunitinib—KDR—head—atopic dermatitis	0.000417	0.00345	CbGeAlD
Sunitinib—MAP2K5—head—atopic dermatitis	0.000417	0.00345	CbGeAlD
Sunitinib—CSF1R—head—atopic dermatitis	0.000407	0.00337	CbGeAlD
Sunitinib—PRPF4—Sirolimus—Pimecrolimus—atopic dermatitis	0.000393	0.0618	CbGdCrCtD
Sunitinib—PRPF4—Temsirolimus—Tacrolimus—atopic dermatitis	0.000393	0.0618	CbGdCrCtD
Sunitinib—PRPF4—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000393	0.0618	CbGdCrCtD
Sunitinib—PRPF4—Sirolimus—Tacrolimus—atopic dermatitis	0.000393	0.0618	CbGdCrCtD
Sunitinib—KIT—head—atopic dermatitis	0.00037	0.00306	CbGeAlD
Sunitinib—PDGFRB—head—atopic dermatitis	0.000361	0.00298	CbGeAlD
Sunitinib—ABCC4—head—atopic dermatitis	0.000287	0.00238	CbGeAlD
Sunitinib—TLK2—Progesterone—Hydrocortisone—atopic dermatitis	0.00023	0.0361	CbGdCrCtD
Sunitinib—KCNH2—head—atopic dermatitis	0.000228	0.00189	CbGeAlD
Sunitinib—PTK2B—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.000202	0.0317	CbGdCrCtD
Sunitinib—TLK2—Progesterone—Prednisolone—atopic dermatitis	0.000194	0.0304	CbGdCrCtD
Sunitinib—MAP4K4—Testosterone Propionate—Hydrocortisone—atopic dermatitis	0.000159	0.0249	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Desonide—atopic dermatitis	0.000117	0.0184	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Desonide—atopic dermatitis	0.000117	0.0184	CbGdCrCtD
Sunitinib—PRPF4—Promazine—Diphenhydramine—atopic dermatitis	0.000112	0.0176	CbGdCrCtD
Sunitinib—Erythema—Hydrocortisone—atopic dermatitis	0.000109	0.00042	CcSEcCtD
Sunitinib—Bradycardia—Betamethasone—atopic dermatitis	0.000109	0.000419	CcSEcCtD
Sunitinib—Bradycardia—Dexamethasone—atopic dermatitis	0.000109	0.000419	CcSEcCtD
Sunitinib—Neutropenia—Prednisone—atopic dermatitis	0.000109	0.000419	CcSEcCtD
Sunitinib—Haemoglobin—Betamethasone—atopic dermatitis	0.000107	0.000414	CcSEcCtD
Sunitinib—Haemoglobin—Dexamethasone—atopic dermatitis	0.000107	0.000414	CcSEcCtD
Sunitinib—Haemorrhage—Betamethasone—atopic dermatitis	0.000107	0.000412	CcSEcCtD
Sunitinib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000107	0.000412	CcSEcCtD
Sunitinib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000107	0.000411	CcSEcCtD
Sunitinib—Nausea—Mometasone—atopic dermatitis	0.000106	0.00041	CcSEcCtD
Sunitinib—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000106	0.000409	CcSEcCtD
Sunitinib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000106	0.000408	CcSEcCtD
Sunitinib—Arrhythmia—Triamcinolone—atopic dermatitis	0.000105	0.000405	CcSEcCtD
Sunitinib—Weight decreased—Prednisone—atopic dermatitis	0.000105	0.000405	CcSEcCtD
Sunitinib—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000105	0.000405	CcSEcCtD
Sunitinib—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000105	0.000404	CcSEcCtD
Sunitinib—Hyperglycaemia—Prednisone—atopic dermatitis	0.000105	0.000404	CcSEcCtD
Sunitinib—Depression—Prednisone—atopic dermatitis	0.000103	0.000398	CcSEcCtD
Sunitinib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000103	0.000397	CcSEcCtD
Sunitinib—Erythema—Triamcinolone—atopic dermatitis	0.000103	0.000395	CcSEcCtD
Sunitinib—Erythema—Methylprednisolone—atopic dermatitis	0.000102	0.000394	CcSEcCtD
Sunitinib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000102	0.000394	CcSEcCtD
Sunitinib—Asthenia—Tacrolimus—atopic dermatitis	0.000102	0.000394	CcSEcCtD
Sunitinib—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000102	0.000394	CcSEcCtD
Sunitinib—Angioedema—Prednisolone—atopic dermatitis	0.000102	0.000393	CcSEcCtD
Sunitinib—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000102	0.000392	CcSEcCtD
Sunitinib—Pruritus—Tacrolimus—atopic dermatitis	0.000101	0.000388	CcSEcCtD
Sunitinib—Dysgeusia—Triamcinolone—atopic dermatitis	0.0001	0.000387	CcSEcCtD
Sunitinib—ABCB1—head—atopic dermatitis	0.0001	0.000827	CbGeAlD
Sunitinib—Eye disorder—Betamethasone—atopic dermatitis	9.99e-05	0.000385	CcSEcCtD
Sunitinib—Eye disorder—Dexamethasone—atopic dermatitis	9.99e-05	0.000385	CcSEcCtD
Sunitinib—Angioedema—Hydrocortisone—atopic dermatitis	9.96e-05	0.000383	CcSEcCtD
Sunitinib—Back pain—Triamcinolone—atopic dermatitis	9.92e-05	0.000382	CcSEcCtD
Sunitinib—Diarrhoea—Tacrolimus—atopic dermatitis	9.75e-05	0.000376	CcSEcCtD
Sunitinib—Angiopathy—Betamethasone—atopic dermatitis	9.7e-05	0.000374	CcSEcCtD
Sunitinib—Angiopathy—Dexamethasone—atopic dermatitis	9.7e-05	0.000374	CcSEcCtD
Sunitinib—Convulsion—Prednisolone—atopic dermatitis	9.67e-05	0.000372	CcSEcCtD
Sunitinib—Hypertension—Prednisolone—atopic dermatitis	9.63e-05	0.000371	CcSEcCtD
Sunitinib—Arrhythmia—Betamethasone—atopic dermatitis	9.55e-05	0.000368	CcSEcCtD
Sunitinib—Arrhythmia—Dexamethasone—atopic dermatitis	9.55e-05	0.000368	CcSEcCtD
Sunitinib—Bradycardia—Prednisone—atopic dermatitis	9.48e-05	0.000365	CcSEcCtD
Sunitinib—Alopecia—Dexamethasone—atopic dermatitis	9.45e-05	0.000364	CcSEcCtD
Sunitinib—Alopecia—Betamethasone—atopic dermatitis	9.45e-05	0.000364	CcSEcCtD
Sunitinib—Convulsion—Hydrocortisone—atopic dermatitis	9.44e-05	0.000364	CcSEcCtD
Sunitinib—Dizziness—Tacrolimus—atopic dermatitis	9.43e-05	0.000363	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Fluocinonide—atopic dermatitis	9.41e-05	0.0148	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Fluocinonide—atopic dermatitis	9.41e-05	0.0148	CbGdCrCtD
Sunitinib—Hypertension—Hydrocortisone—atopic dermatitis	9.41e-05	0.000362	CcSEcCtD
Sunitinib—Angioedema—Triamcinolone—atopic dermatitis	9.37e-05	0.000361	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—atopic dermatitis	9.36e-05	0.00036	CcSEcCtD
Sunitinib—Angioedema—Methylprednisolone—atopic dermatitis	9.35e-05	0.00036	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—atopic dermatitis	9.31e-05	0.000359	CcSEcCtD
Sunitinib—Erythema—Dexamethasone—atopic dermatitis	9.31e-05	0.000359	CcSEcCtD
Sunitinib—Erythema—Betamethasone—atopic dermatitis	9.31e-05	0.000359	CcSEcCtD
Sunitinib—Myalgia—Hydrocortisone—atopic dermatitis	9.28e-05	0.000357	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	9.21e-05	0.000355	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—atopic dermatitis	9.15e-05	0.000352	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	9.14e-05	0.0144	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	9.14e-05	0.0144	CbGdCrCtD
Sunitinib—Oedema—Prednisolone—atopic dermatitis	9.11e-05	0.000351	CcSEcCtD
Sunitinib—Vomiting—Tacrolimus—atopic dermatitis	9.06e-05	0.000349	CcSEcCtD
Sunitinib—Rash—Tacrolimus—atopic dermatitis	8.99e-05	0.000346	CcSEcCtD
Sunitinib—Dermatitis—Tacrolimus—atopic dermatitis	8.98e-05	0.000346	CcSEcCtD
Sunitinib—Shock—Prednisolone—atopic dermatitis	8.96e-05	0.000345	CcSEcCtD
Sunitinib—Cough—Triamcinolone—atopic dermatitis	8.95e-05	0.000345	CcSEcCtD
Sunitinib—Headache—Tacrolimus—atopic dermatitis	8.93e-05	0.000344	CcSEcCtD
Sunitinib—Oedema—Hydrocortisone—atopic dermatitis	8.89e-05	0.000342	CcSEcCtD
Sunitinib—Convulsion—Triamcinolone—atopic dermatitis	8.89e-05	0.000342	CcSEcCtD
Sunitinib—Convulsion—Methylprednisolone—atopic dermatitis	8.87e-05	0.000342	CcSEcCtD
Sunitinib—Hypertension—Triamcinolone—atopic dermatitis	8.86e-05	0.000341	CcSEcCtD
Sunitinib—Hypertension—Methylprednisolone—atopic dermatitis	8.84e-05	0.00034	CcSEcCtD
Sunitinib—Infection—Hydrocortisone—atopic dermatitis	8.83e-05	0.00034	CcSEcCtD
Sunitinib—Shock—Hydrocortisone—atopic dermatitis	8.75e-05	0.000337	CcSEcCtD
Sunitinib—Myalgia—Triamcinolone—atopic dermatitis	8.73e-05	0.000336	CcSEcCtD
Sunitinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	8.72e-05	0.000336	CcSEcCtD
Sunitinib—Myalgia—Methylprednisolone—atopic dermatitis	8.72e-05	0.000336	CcSEcCtD
Sunitinib—Arthralgia—Methylprednisolone—atopic dermatitis	8.72e-05	0.000336	CcSEcCtD
Sunitinib—Eye disorder—Prednisone—atopic dermatitis	8.7e-05	0.000335	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	8.66e-05	0.000333	CcSEcCtD
Sunitinib—Flushing—Prednisone—atopic dermatitis	8.64e-05	0.000333	CcSEcCtD
Sunitinib—Skin disorder—Hydrocortisone—atopic dermatitis	8.64e-05	0.000333	CcSEcCtD
Sunitinib—Dry mouth—Triamcinolone—atopic dermatitis	8.54e-05	0.000329	CcSEcCtD
Sunitinib—Angioedema—Betamethasone—atopic dermatitis	8.51e-05	0.000328	CcSEcCtD
Sunitinib—Angioedema—Dexamethasone—atopic dermatitis	8.51e-05	0.000328	CcSEcCtD
Sunitinib—Anorexia—Hydrocortisone—atopic dermatitis	8.48e-05	0.000326	CcSEcCtD
Sunitinib—Nausea—Tacrolimus—atopic dermatitis	8.47e-05	0.000326	CcSEcCtD
Sunitinib—Angiopathy—Prednisone—atopic dermatitis	8.45e-05	0.000325	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—atopic dermatitis	8.41e-05	0.000324	CcSEcCtD
Sunitinib—Oedema—Triamcinolone—atopic dermatitis	8.37e-05	0.000322	CcSEcCtD
Sunitinib—Arrhythmia—Prednisone—atopic dermatitis	8.32e-05	0.00032	CcSEcCtD
Sunitinib—Infection—Triamcinolone—atopic dermatitis	8.32e-05	0.00032	CcSEcCtD
Sunitinib—Infection—Methylprednisolone—atopic dermatitis	8.3e-05	0.00032	CcSEcCtD
Sunitinib—Shock—Triamcinolone—atopic dermatitis	8.24e-05	0.000317	CcSEcCtD
Sunitinib—Insomnia—Prednisolone—atopic dermatitis	8.24e-05	0.000317	CcSEcCtD
Sunitinib—Alopecia—Prednisone—atopic dermatitis	8.23e-05	0.000317	CcSEcCtD
Sunitinib—Shock—Methylprednisolone—atopic dermatitis	8.22e-05	0.000317	CcSEcCtD
Sunitinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	8.19e-05	0.000316	CcSEcCtD
Sunitinib—Paraesthesia—Prednisolone—atopic dermatitis	8.18e-05	0.000315	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—atopic dermatitis	8.16e-05	0.000314	CcSEcCtD
Sunitinib—Skin disorder—Methylprednisolone—atopic dermatitis	8.12e-05	0.000313	CcSEcCtD
Sunitinib—Malnutrition—Prednisone—atopic dermatitis	8.11e-05	0.000312	CcSEcCtD
Sunitinib—Erythema—Prednisone—atopic dermatitis	8.11e-05	0.000312	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	8.1e-05	0.000312	CcSEcCtD
Sunitinib—Convulsion—Betamethasone—atopic dermatitis	8.07e-05	0.000311	CcSEcCtD
Sunitinib—Convulsion—Dexamethasone—atopic dermatitis	8.07e-05	0.000311	CcSEcCtD
Sunitinib—Insomnia—Hydrocortisone—atopic dermatitis	8.04e-05	0.00031	CcSEcCtD
Sunitinib—Hypertension—Betamethasone—atopic dermatitis	8.04e-05	0.00031	CcSEcCtD
Sunitinib—Hypertension—Dexamethasone—atopic dermatitis	8.04e-05	0.00031	CcSEcCtD
Sunitinib—Paraesthesia—Hydrocortisone—atopic dermatitis	7.99e-05	0.000308	CcSEcCtD
Sunitinib—Myalgia—Betamethasone—atopic dermatitis	7.93e-05	0.000305	CcSEcCtD
Sunitinib—Myalgia—Dexamethasone—atopic dermatitis	7.93e-05	0.000305	CcSEcCtD
Sunitinib—Dyspepsia—Hydrocortisone—atopic dermatitis	7.83e-05	0.000301	CcSEcCtD
Sunitinib—Pain—Prednisolone—atopic dermatitis	7.79e-05	0.0003	CcSEcCtD
Sunitinib—Decreased appetite—Hydrocortisone—atopic dermatitis	7.73e-05	0.000298	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.68e-05	0.000296	CcSEcCtD
Sunitinib—Fatigue—Hydrocortisone—atopic dermatitis	7.67e-05	0.000295	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	7.63e-05	0.000294	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	7.61e-05	0.000293	CcSEcCtD
Sunitinib—Pain—Hydrocortisone—atopic dermatitis	7.6e-05	0.000293	CcSEcCtD
Sunitinib—Oedema—Dexamethasone—atopic dermatitis	7.6e-05	0.000293	CcSEcCtD
Sunitinib—Oedema—Betamethasone—atopic dermatitis	7.6e-05	0.000293	CcSEcCtD
Sunitinib—Insomnia—Triamcinolone—atopic dermatitis	7.57e-05	0.000292	CcSEcCtD
Sunitinib—Insomnia—Methylprednisolone—atopic dermatitis	7.56e-05	0.000291	CcSEcCtD
Sunitinib—Infection—Dexamethasone—atopic dermatitis	7.55e-05	0.000291	CcSEcCtD
Sunitinib—Infection—Betamethasone—atopic dermatitis	7.55e-05	0.000291	CcSEcCtD
Sunitinib—Paraesthesia—Triamcinolone—atopic dermatitis	7.52e-05	0.00029	CcSEcCtD
Sunitinib—Paraesthesia—Methylprednisolone—atopic dermatitis	7.5e-05	0.000289	CcSEcCtD
Sunitinib—Anaemia—Prednisone—atopic dermatitis	7.49e-05	0.000289	CcSEcCtD
Sunitinib—Shock—Betamethasone—atopic dermatitis	7.47e-05	0.000288	CcSEcCtD
Sunitinib—Shock—Dexamethasone—atopic dermatitis	7.47e-05	0.000288	CcSEcCtD
Sunitinib—Dyspnoea—Triamcinolone—atopic dermatitis	7.47e-05	0.000287	CcSEcCtD
Sunitinib—Nervous system disorder—Dexamethasone—atopic dermatitis	7.45e-05	0.000287	CcSEcCtD
Sunitinib—Nervous system disorder—Betamethasone—atopic dermatitis	7.45e-05	0.000287	CcSEcCtD
Sunitinib—Thrombocytopenia—Dexamethasone—atopic dermatitis	7.44e-05	0.000286	CcSEcCtD
Sunitinib—Thrombocytopenia—Betamethasone—atopic dermatitis	7.44e-05	0.000286	CcSEcCtD
Sunitinib—Angioedema—Prednisone—atopic dermatitis	7.41e-05	0.000285	CcSEcCtD
Sunitinib—Dyspepsia—Triamcinolone—atopic dermatitis	7.37e-05	0.000284	CcSEcCtD
Sunitinib—Dyspepsia—Methylprednisolone—atopic dermatitis	7.35e-05	0.000283	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Mometasone—atopic dermatitis	7.29e-05	0.0115	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Mometasone—atopic dermatitis	7.29e-05	0.0115	CbGdCrCtD
Sunitinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	7.27e-05	0.00028	CcSEcCtD
Sunitinib—Anorexia—Dexamethasone—atopic dermatitis	7.24e-05	0.000279	CcSEcCtD
Sunitinib—Anorexia—Betamethasone—atopic dermatitis	7.24e-05	0.000279	CcSEcCtD
Sunitinib—CSNK1E—Danazol—Hydrocortisone—atopic dermatitis	7.23e-05	0.0114	CbGdCrCtD
Sunitinib—Fatigue—Triamcinolone—atopic dermatitis	7.22e-05	0.000278	CcSEcCtD
Sunitinib—Fatigue—Methylprednisolone—atopic dermatitis	7.2e-05	0.000277	CcSEcCtD
Sunitinib—Pain—Triamcinolone—atopic dermatitis	7.16e-05	0.000276	CcSEcCtD
Sunitinib—Body temperature increased—Hydrocortisone—atopic dermatitis	7.03e-05	0.000271	CcSEcCtD
Sunitinib—Abdominal pain—Hydrocortisone—atopic dermatitis	7.03e-05	0.000271	CcSEcCtD
Sunitinib—Convulsion—Prednisone—atopic dermatitis	7.02e-05	0.000271	CcSEcCtD
Sunitinib—Hypertension—Prednisone—atopic dermatitis	7e-05	0.00027	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	6.92e-05	0.000267	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	6.92e-05	0.000267	CcSEcCtD
Sunitinib—Myalgia—Prednisone—atopic dermatitis	6.9e-05	0.000266	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—atopic dermatitis	6.9e-05	0.000266	CcSEcCtD
Sunitinib—Insomnia—Dexamethasone—atopic dermatitis	6.87e-05	0.000265	CcSEcCtD
Sunitinib—Insomnia—Betamethasone—atopic dermatitis	6.87e-05	0.000265	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	6.85e-05	0.000264	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	6.83e-05	0.000263	CcSEcCtD
Sunitinib—Paraesthesia—Betamethasone—atopic dermatitis	6.82e-05	0.000263	CcSEcCtD
Sunitinib—Paraesthesia—Dexamethasone—atopic dermatitis	6.82e-05	0.000263	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisolone—atopic dermatitis	6.71e-05	0.000258	CcSEcCtD
Sunitinib—Dyspepsia—Betamethasone—atopic dermatitis	6.69e-05	0.000258	CcSEcCtD
Sunitinib—Dyspepsia—Dexamethasone—atopic dermatitis	6.69e-05	0.000258	CcSEcCtD
Sunitinib—Body temperature increased—Triamcinolone—atopic dermatitis	6.62e-05	0.000255	CcSEcCtD
Sunitinib—Oedema—Prednisone—atopic dermatitis	6.62e-05	0.000255	CcSEcCtD
Sunitinib—Abdominal pain—Methylprednisolone—atopic dermatitis	6.6e-05	0.000254	CcSEcCtD
Sunitinib—Decreased appetite—Dexamethasone—atopic dermatitis	6.6e-05	0.000254	CcSEcCtD
Sunitinib—Decreased appetite—Betamethasone—atopic dermatitis	6.6e-05	0.000254	CcSEcCtD
Sunitinib—Infection—Prednisone—atopic dermatitis	6.57e-05	0.000253	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.56e-05	0.000253	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.56e-05	0.000253	CcSEcCtD
Sunitinib—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.55e-05	0.000252	CcSEcCtD
Sunitinib—Fatigue—Dexamethasone—atopic dermatitis	6.55e-05	0.000252	CcSEcCtD
Sunitinib—Fatigue—Betamethasone—atopic dermatitis	6.55e-05	0.000252	CcSEcCtD
Sunitinib—Shock—Prednisone—atopic dermatitis	6.51e-05	0.000251	CcSEcCtD
Sunitinib—Pain—Dexamethasone—atopic dermatitis	6.5e-05	0.00025	CcSEcCtD
Sunitinib—Pain—Betamethasone—atopic dermatitis	6.5e-05	0.00025	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—atopic dermatitis	6.49e-05	0.00025	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—atopic dermatitis	6.43e-05	0.000248	CcSEcCtD
Sunitinib—Asthenia—Hydrocortisone—atopic dermatitis	6.38e-05	0.000246	CcSEcCtD
Sunitinib—Anorexia—Prednisone—atopic dermatitis	6.31e-05	0.000243	CcSEcCtD
Sunitinib—Pruritus—Hydrocortisone—atopic dermatitis	6.29e-05	0.000242	CcSEcCtD
Sunitinib—CSNK1E—Danazol—Prednisone—atopic dermatitis	6.23e-05	0.00978	CbGdCrCtD
Sunitinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	6.21e-05	0.000239	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	6.21e-05	0.000239	CcSEcCtD
Sunitinib—Hypersensitivity—Triamcinolone—atopic dermatitis	6.17e-05	0.000238	CcSEcCtD
Sunitinib—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.16e-05	0.000237	CcSEcCtD
Sunitinib—Diarrhoea—Hydrocortisone—atopic dermatitis	6.08e-05	0.000234	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.03e-05	0.000232	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—atopic dermatitis	6.02e-05	0.000232	CcSEcCtD
Sunitinib—Asthenia—Triamcinolone—atopic dermatitis	6.01e-05	0.000231	CcSEcCtD
Sunitinib—Body temperature increased—Dexamethasone—atopic dermatitis	6.01e-05	0.000231	CcSEcCtD
Sunitinib—Abdominal pain—Dexamethasone—atopic dermatitis	6.01e-05	0.000231	CcSEcCtD
Sunitinib—Abdominal pain—Betamethasone—atopic dermatitis	6.01e-05	0.000231	CcSEcCtD
Sunitinib—Body temperature increased—Betamethasone—atopic dermatitis	6.01e-05	0.000231	CcSEcCtD
Sunitinib—Asthenia—Methylprednisolone—atopic dermatitis	5.99e-05	0.000231	CcSEcCtD
Sunitinib—Insomnia—Prednisone—atopic dermatitis	5.98e-05	0.00023	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—atopic dermatitis	5.94e-05	0.000229	CcSEcCtD
Sunitinib—Pruritus—Triamcinolone—atopic dermatitis	5.92e-05	0.000228	CcSEcCtD
Sunitinib—Pruritus—Methylprednisolone—atopic dermatitis	5.91e-05	0.000228	CcSEcCtD
Sunitinib—Dizziness—Hydrocortisone—atopic dermatitis	5.88e-05	0.000226	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—atopic dermatitis	5.82e-05	0.000224	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—atopic dermatitis	5.75e-05	0.000222	CcSEcCtD
Sunitinib—Rash—Prednisolone—atopic dermatitis	5.74e-05	0.000221	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—atopic dermatitis	5.74e-05	0.000221	CcSEcCtD
Sunitinib—Diarrhoea—Methylprednisolone—atopic dermatitis	5.72e-05	0.00022	CcSEcCtD
Sunitinib—Fatigue—Prednisone—atopic dermatitis	5.7e-05	0.00022	CcSEcCtD
Sunitinib—Headache—Prednisolone—atopic dermatitis	5.7e-05	0.00022	CcSEcCtD
Sunitinib—Constipation—Prednisone—atopic dermatitis	5.66e-05	0.000218	CcSEcCtD
Sunitinib—Vomiting—Hydrocortisone—atopic dermatitis	5.65e-05	0.000218	CcSEcCtD
Sunitinib—Rash—Hydrocortisone—atopic dermatitis	5.61e-05	0.000216	CcSEcCtD
Sunitinib—Dermatitis—Hydrocortisone—atopic dermatitis	5.6e-05	0.000216	CcSEcCtD
Sunitinib—Headache—Hydrocortisone—atopic dermatitis	5.57e-05	0.000215	CcSEcCtD
Sunitinib—Dizziness—Triamcinolone—atopic dermatitis	5.54e-05	0.000213	CcSEcCtD
Sunitinib—Dizziness—Methylprednisolone—atopic dermatitis	5.52e-05	0.000213	CcSEcCtD
Sunitinib—Asthenia—Betamethasone—atopic dermatitis	5.45e-05	0.00021	CcSEcCtD
Sunitinib—Asthenia—Dexamethasone—atopic dermatitis	5.45e-05	0.00021	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—atopic dermatitis	5.41e-05	0.000208	CcSEcCtD
Sunitinib—Nausea—Prednisolone—atopic dermatitis	5.41e-05	0.000208	CcSEcCtD
Sunitinib—Pruritus—Betamethasone—atopic dermatitis	5.38e-05	0.000207	CcSEcCtD
Sunitinib—Pruritus—Dexamethasone—atopic dermatitis	5.38e-05	0.000207	CcSEcCtD
Sunitinib—Vomiting—Triamcinolone—atopic dermatitis	5.32e-05	0.000205	CcSEcCtD
Sunitinib—Vomiting—Methylprednisolone—atopic dermatitis	5.31e-05	0.000205	CcSEcCtD
Sunitinib—Nausea—Hydrocortisone—atopic dermatitis	5.28e-05	0.000203	CcSEcCtD
Sunitinib—Rash—Triamcinolone—atopic dermatitis	5.28e-05	0.000203	CcSEcCtD
Sunitinib—Dermatitis—Triamcinolone—atopic dermatitis	5.27e-05	0.000203	CcSEcCtD
Sunitinib—Rash—Methylprednisolone—atopic dermatitis	5.27e-05	0.000203	CcSEcCtD
Sunitinib—Dermatitis—Methylprednisolone—atopic dermatitis	5.26e-05	0.000203	CcSEcCtD
Sunitinib—Headache—Triamcinolone—atopic dermatitis	5.25e-05	0.000202	CcSEcCtD
Sunitinib—Headache—Methylprednisolone—atopic dermatitis	5.23e-05	0.000202	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—atopic dermatitis	5.23e-05	0.000201	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—atopic dermatitis	5.23e-05	0.000201	CcSEcCtD
Sunitinib—Diarrhoea—Betamethasone—atopic dermatitis	5.2e-05	0.0002	CcSEcCtD
Sunitinib—Diarrhoea—Dexamethasone—atopic dermatitis	5.2e-05	0.0002	CcSEcCtD
Sunitinib—Dizziness—Betamethasone—atopic dermatitis	5.02e-05	0.000193	CcSEcCtD
Sunitinib—Dizziness—Dexamethasone—atopic dermatitis	5.02e-05	0.000193	CcSEcCtD
Sunitinib—Nausea—Triamcinolone—atopic dermatitis	4.97e-05	0.000192	CcSEcCtD
Sunitinib—Nausea—Methylprednisolone—atopic dermatitis	4.96e-05	0.000191	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisone—atopic dermatitis	4.87e-05	0.000188	CcSEcCtD
Sunitinib—Vomiting—Dexamethasone—atopic dermatitis	4.83e-05	0.000186	CcSEcCtD
Sunitinib—Vomiting—Betamethasone—atopic dermatitis	4.83e-05	0.000186	CcSEcCtD
Sunitinib—Rash—Dexamethasone—atopic dermatitis	4.79e-05	0.000184	CcSEcCtD
Sunitinib—Rash—Betamethasone—atopic dermatitis	4.79e-05	0.000184	CcSEcCtD
Sunitinib—Dermatitis—Dexamethasone—atopic dermatitis	4.79e-05	0.000184	CcSEcCtD
Sunitinib—Dermatitis—Betamethasone—atopic dermatitis	4.79e-05	0.000184	CcSEcCtD
Sunitinib—PRPF4—Norethindrone—Hydrocortisone—atopic dermatitis	4.78e-05	0.00751	CbGdCrCtD
Sunitinib—Headache—Betamethasone—atopic dermatitis	4.76e-05	0.000183	CcSEcCtD
Sunitinib—Headache—Dexamethasone—atopic dermatitis	4.76e-05	0.000183	CcSEcCtD
Sunitinib—Asthenia—Prednisone—atopic dermatitis	4.75e-05	0.000183	CcSEcCtD
Sunitinib—Pruritus—Prednisone—atopic dermatitis	4.68e-05	0.00018	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Hydrocortisone—atopic dermatitis	4.62e-05	0.00725	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Hydrocortisone—atopic dermatitis	4.62e-05	0.00725	CbGdCrCtD
Sunitinib—Diarrhoea—Prednisone—atopic dermatitis	4.53e-05	0.000174	CcSEcCtD
Sunitinib—Nausea—Betamethasone—atopic dermatitis	4.51e-05	0.000174	CcSEcCtD
Sunitinib—Nausea—Dexamethasone—atopic dermatitis	4.51e-05	0.000174	CcSEcCtD
Sunitinib—CHEK2—Testosterone Propionate—Hydrocortisone—atopic dermatitis	4.45e-05	0.00699	CbGdCrCtD
Sunitinib—Dizziness—Prednisone—atopic dermatitis	4.38e-05	0.000169	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Methylprednisolone—atopic dermatitis	4.36e-05	0.00684	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Methylprednisolone—atopic dermatitis	4.36e-05	0.00684	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Dexamethasone—atopic dermatitis	4.29e-05	0.00673	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Betamethasone—atopic dermatitis	4.29e-05	0.00673	CbGdCrCtD
Sunitinib—Vomiting—Prednisone—atopic dermatitis	4.21e-05	0.000162	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Triamcinolone—atopic dermatitis	4.19e-05	0.00658	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Triamcinolone—atopic dermatitis	4.19e-05	0.00658	CbGdCrCtD
Sunitinib—Rash—Prednisone—atopic dermatitis	4.17e-05	0.000161	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—atopic dermatitis	4.17e-05	0.000161	CcSEcCtD
Sunitinib—Headache—Prednisone—atopic dermatitis	4.15e-05	0.00016	CcSEcCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—atopic dermatitis	3.98e-05	0.00624	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—atopic dermatitis	3.98e-05	0.00624	CbGdCrCtD
Sunitinib—Nausea—Prednisone—atopic dermatitis	3.93e-05	0.000151	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—atopic dermatitis	3.88e-05	0.00609	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—atopic dermatitis	3.88e-05	0.00609	CbGdCrCtD
Sunitinib—PRPF4—Levonorgestrel—Hydrocortisone—atopic dermatitis	3.81e-05	0.00597	CbGdCrCtD
Sunitinib—CHEK2—Danazol—Hydrocortisone—atopic dermatitis	3.7e-05	0.00581	CbGdCrCtD
Sunitinib—CHEK2—Norethindrone—Hydrocortisone—atopic dermatitis	3.34e-05	0.00524	CbGdCrCtD
Sunitinib—CHEK2—Danazol—Prednisone—atopic dermatitis	3.19e-05	0.00501	CbGdCrCtD
Sunitinib—CHEK2—Levonorgestrel—Hydrocortisone—atopic dermatitis	2.65e-05	0.00417	CbGdCrCtD
Sunitinib—FGFR1—Signaling Pathways—CCR5—atopic dermatitis	4.52e-06	1.73e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCR5—atopic dermatitis	4.5e-06	1.73e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	4.5e-06	1.73e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—IL6—atopic dermatitis	4.49e-06	1.72e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CXCL8—atopic dermatitis	4.48e-06	1.72e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—IL6—atopic dermatitis	4.42e-06	1.69e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—IL6—atopic dermatitis	4.42e-06	1.69e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IL6—atopic dermatitis	4.4e-06	1.69e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL1B—atopic dermatitis	4.4e-06	1.69e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CD4—atopic dermatitis	4.4e-06	1.69e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CASP8—atopic dermatitis	4.4e-06	1.68e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD4—atopic dermatitis	4.39e-06	1.68e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL2—atopic dermatitis	4.38e-06	1.68e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—MAPK8—atopic dermatitis	4.38e-06	1.68e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD4—atopic dermatitis	4.37e-06	1.68e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—IL6—atopic dermatitis	4.37e-06	1.67e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL1B—atopic dermatitis	4.35e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CD4—atopic dermatitis	4.34e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCL5—atopic dermatitis	4.34e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL2—atopic dermatitis	4.33e-06	1.66e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCL5—atopic dermatitis	4.32e-06	1.65e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL2—atopic dermatitis	4.32e-06	1.65e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IL6—atopic dermatitis	4.3e-06	1.65e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—IL6—atopic dermatitis	4.29e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—IL6—atopic dermatitis	4.29e-06	1.64e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NFKBIA—atopic dermatitis	4.28e-06	1.64e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL2—atopic dermatitis	4.28e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NGF—atopic dermatitis	4.27e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1B—atopic dermatitis	4.27e-06	1.63e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1B—atopic dermatitis	4.27e-06	1.63e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CD4—atopic dermatitis	4.27e-06	1.63e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL6—atopic dermatitis	4.26e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—CXCL8—atopic dermatitis	4.26e-06	1.63e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL2—atopic dermatitis	4.25e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL2—atopic dermatitis	4.25e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—IL6—atopic dermatitis	4.25e-06	1.63e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MAPK8—atopic dermatitis	4.24e-06	1.62e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL6—atopic dermatitis	4.2e-06	1.61e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL6—atopic dermatitis	4.2e-06	1.61e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.19e-06	1.6e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IFNG—atopic dermatitis	4.18e-06	1.6e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.18e-06	1.6e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	4.17e-06	1.6e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NFKBIA—atopic dermatitis	4.16e-06	1.59e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCR5—atopic dermatitis	4.16e-06	1.59e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—MAPK8—atopic dermatitis	4.16e-06	1.59e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCL5—atopic dermatitis	4.13e-06	1.58e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NFKBIA—atopic dermatitis	4.11e-06	1.57e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CXCL8—atopic dermatitis	4.1e-06	1.57e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IFNG—atopic dermatitis	4.08e-06	1.56e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—IL6—atopic dermatitis	4.07e-06	1.56e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL6—atopic dermatitis	4.07e-06	1.56e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL2—atopic dermatitis	4.07e-06	1.56e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IL6—atopic dermatitis	4.06e-06	1.56e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	4.06e-06	1.55e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1B—atopic dermatitis	4.05e-06	1.55e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CD4—atopic dermatitis	4.05e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1B—atopic dermatitis	4.04e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CD4—atopic dermatitis	4.04e-06	1.55e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD4—atopic dermatitis	4.04e-06	1.55e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL2—atopic dermatitis	4.04e-06	1.55e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—MAPK8—atopic dermatitis	4.04e-06	1.55e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NFKBIA—atopic dermatitis	4.03e-06	1.55e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NFKBIA—atopic dermatitis	4.03e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL2—atopic dermatitis	4.03e-06	1.54e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NGF—atopic dermatitis	4.02e-06	1.54e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—IL2—atopic dermatitis	4e-06	1.53e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NGF—atopic dermatitis	4e-06	1.53e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—atopic dermatitis	4e-06	1.53e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—atopic dermatitis	3.99e-06	1.53e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—MAPK8—atopic dermatitis	3.99e-06	1.53e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—CXCL8—atopic dermatitis	3.98e-06	1.53e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MAPK8—atopic dermatitis	3.97e-06	1.52e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—atopic dermatitis	3.97e-06	1.52e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CXCL8—atopic dermatitis	3.95e-06	1.51e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD4—atopic dermatitis	3.94e-06	1.51e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MAPK8—atopic dermatitis	3.94e-06	1.51e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IFNG—atopic dermatitis	3.93e-06	1.51e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CXCL8—atopic dermatitis	3.93e-06	1.5e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL2—atopic dermatitis	3.92e-06	1.5e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—MAPK8—atopic dermatitis	3.91e-06	1.5e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—MAPK8—atopic dermatitis	3.91e-06	1.5e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IFNG—atopic dermatitis	3.91e-06	1.5e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCR5—atopic dermatitis	3.91e-06	1.5e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCR5—atopic dermatitis	3.89e-06	1.49e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—atopic dermatitis	3.89e-06	1.49e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—atopic dermatitis	3.86e-06	1.48e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NFKBIA—atopic dermatitis	3.83e-06	1.47e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NGF—atopic dermatitis	3.82e-06	1.46e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NFKBIA—atopic dermatitis	3.82e-06	1.46e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CXCL8—atopic dermatitis	3.81e-06	1.46e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CXCL8—atopic dermatitis	3.81e-06	1.46e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—CXCL8—atopic dermatitis	3.81e-06	1.46e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL2—atopic dermatitis	3.81e-06	1.46e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD4—atopic dermatitis	3.8e-06	1.46e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—atopic dermatitis	3.8e-06	1.45e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD4—atopic dermatitis	3.78e-06	1.45e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL2—atopic dermatitis	3.78e-06	1.45e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—atopic dermatitis	3.76e-06	1.44e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—atopic dermatitis	3.76e-06	1.44e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL2—atopic dermatitis	3.75e-06	1.44e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—atopic dermatitis	3.75e-06	1.44e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IFNG—atopic dermatitis	3.74e-06	1.43e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—atopic dermatitis	3.73e-06	1.43e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CD4—atopic dermatitis	3.73e-06	1.43e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCR5—atopic dermatitis	3.72e-06	1.42e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL2—atopic dermatitis	3.72e-06	1.42e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—MAPK8—atopic dermatitis	3.71e-06	1.42e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.71e-06	1.42e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CXCL8—atopic dermatitis	3.71e-06	1.42e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—MAPK8—atopic dermatitis	3.7e-06	1.42e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	3.66e-06	1.4e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—atopic dermatitis	3.64e-06	1.39e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CD4—atopic dermatitis	3.64e-06	1.39e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL2—atopic dermatitis	3.64e-06	1.39e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL2—atopic dermatitis	3.64e-06	1.39e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL2—atopic dermatitis	3.64e-06	1.39e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL2—atopic dermatitis	3.63e-06	1.39e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PPARA—atopic dermatitis	3.62e-06	1.39e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD4—atopic dermatitis	3.61e-06	1.38e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MAPK8—atopic dermatitis	3.61e-06	1.38e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.59e-06	1.37e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—atopic dermatitis	3.56e-06	1.37e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.56e-06	1.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—atopic dermatitis	3.55e-06	1.36e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL2—atopic dermatitis	3.55e-06	1.36e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—atopic dermatitis	3.53e-06	1.35e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NFKBIA—atopic dermatitis	3.53e-06	1.35e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—atopic dermatitis	3.51e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—atopic dermatitis	3.51e-06	1.34e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—atopic dermatitis	3.51e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—CD4—atopic dermatitis	3.51e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL2—atopic dermatitis	3.5e-06	1.34e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—atopic dermatitis	3.49e-06	1.34e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CD4—atopic dermatitis	3.49e-06	1.34e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—atopic dermatitis	3.48e-06	1.33e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL2—atopic dermatitis	3.48e-06	1.33e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MAPK8—atopic dermatitis	3.48e-06	1.33e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—atopic dermatitis	3.47e-06	1.33e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MAPK8—atopic dermatitis	3.45e-06	1.32e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	3.44e-06	1.32e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—MAPK8—atopic dermatitis	3.42e-06	1.31e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—atopic dermatitis	3.35e-06	1.28e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MAPK8—atopic dermatitis	3.35e-06	1.28e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MAPK8—atopic dermatitis	3.35e-06	1.28e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—atopic dermatitis	3.35e-06	1.28e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—MAPK8—atopic dermatitis	3.34e-06	1.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—atopic dermatitis	3.34e-06	1.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—atopic dermatitis	3.33e-06	1.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—atopic dermatitis	3.32e-06	1.27e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NFKBIA—atopic dermatitis	3.32e-06	1.27e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NFKBIA—atopic dermatitis	3.3e-06	1.26e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MAPK8—atopic dermatitis	3.26e-06	1.25e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CXCL8—atopic dermatitis	3.22e-06	1.23e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—MAPK8—atopic dermatitis	3.22e-06	1.23e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—MAPK8—atopic dermatitis	3.2e-06	1.23e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—atopic dermatitis	3.16e-06	1.21e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NFKBIA—atopic dermatitis	3.15e-06	1.21e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—atopic dermatitis	3.13e-06	1.2e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—atopic dermatitis	3.08e-06	1.18e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—MAPK8—atopic dermatitis	3.06e-06	1.17e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CXCL8—atopic dermatitis	3.06e-06	1.17e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CXCL8—atopic dermatitis	2.97e-06	1.14e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CXCL8—atopic dermatitis	2.93e-06	1.12e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—atopic dermatitis	2.92e-06	1.12e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CXCL8—atopic dermatitis	2.88e-06	1.1e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CXCL8—atopic dermatitis	2.88e-06	1.1e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—atopic dermatitis	2.83e-06	1.09e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK8—atopic dermatitis	2.83e-06	1.09e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—atopic dermatitis	2.82e-06	1.08e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—atopic dermatitis	2.8e-06	1.07e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—atopic dermatitis	2.8e-06	1.07e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—atopic dermatitis	2.75e-06	1.05e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—atopic dermatitis	2.75e-06	1.05e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CXCL8—atopic dermatitis	2.73e-06	1.05e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CXCL8—atopic dermatitis	2.72e-06	1.04e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—atopic dermatitis	2.71e-06	1.04e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-06	1.03e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—atopic dermatitis	2.65e-06	1.02e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—atopic dermatitis	2.61e-06	9.99e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK8—atopic dermatitis	2.61e-06	9.99e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—atopic dermatitis	2.6e-06	9.97e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.59e-06	9.93e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—atopic dermatitis	2.58e-06	9.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK8—atopic dermatitis	2.58e-06	9.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—atopic dermatitis	2.54e-06	9.75e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—atopic dermatitis	2.54e-06	9.72e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK8—atopic dermatitis	2.53e-06	9.69e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK8—atopic dermatitis	2.53e-06	9.69e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—atopic dermatitis	2.52e-06	9.63e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CXCL8—atopic dermatitis	2.51e-06	9.63e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—atopic dermatitis	2.5e-06	9.57e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—atopic dermatitis	2.5e-06	9.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	2.45e-06	9.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—atopic dermatitis	2.4e-06	9.2e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK8—atopic dermatitis	2.4e-06	9.2e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK8—atopic dermatitis	2.4e-06	9.18e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—atopic dermatitis	2.39e-06	9.16e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—atopic dermatitis	2.38e-06	9.11e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—atopic dermatitis	2.37e-06	9.09e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—atopic dermatitis	2.37e-06	9.06e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—atopic dermatitis	2.36e-06	9.06e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—atopic dermatitis	2.35e-06	9.01e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—atopic dermatitis	2.35e-06	9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	2.34e-06	8.98e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—atopic dermatitis	2.31e-06	8.84e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—atopic dermatitis	2.3e-06	8.83e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—atopic dermatitis	2.26e-06	8.66e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—atopic dermatitis	2.25e-06	8.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—atopic dermatitis	2.25e-06	8.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—atopic dermatitis	2.24e-06	8.57e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—atopic dermatitis	2.22e-06	8.5e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK8—atopic dermatitis	2.21e-06	8.47e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—atopic dermatitis	2.21e-06	8.45e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—atopic dermatitis	2.19e-06	8.39e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—atopic dermatitis	2.18e-06	8.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—atopic dermatitis	2.18e-06	8.37e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	2.16e-06	8.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—atopic dermatitis	2.15e-06	8.23e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—atopic dermatitis	2.14e-06	8.19e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—atopic dermatitis	2.14e-06	8.19e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—atopic dermatitis	2.14e-06	8.19e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—atopic dermatitis	2.13e-06	8.16e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—atopic dermatitis	2.08e-06	7.98e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—atopic dermatitis	2.08e-06	7.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—atopic dermatitis	2.07e-06	7.92e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—atopic dermatitis	2.05e-06	7.87e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—atopic dermatitis	2.04e-06	7.83e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—atopic dermatitis	2.02e-06	7.72e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—atopic dermatitis	1.98e-06	7.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—atopic dermatitis	1.97e-06	7.54e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARA—atopic dermatitis	1.96e-06	7.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—atopic dermatitis	1.95e-06	7.48e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—atopic dermatitis	1.9e-06	7.27e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—atopic dermatitis	1.89e-06	7.23e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—atopic dermatitis	1.81e-06	6.93e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—atopic dermatitis	1.8e-06	6.91e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—atopic dermatitis	1.72e-06	6.57e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—atopic dermatitis	1.67e-06	6.38e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—atopic dermatitis	1.65e-06	6.3e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—atopic dermatitis	1.62e-06	6.19e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—atopic dermatitis	1.62e-06	6.19e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—atopic dermatitis	1.53e-06	5.87e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—atopic dermatitis	1.53e-06	5.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—atopic dermatitis	1.41e-06	5.41e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	1.38e-06	5.28e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—atopic dermatitis	1.33e-06	5.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—atopic dermatitis	1.32e-06	5.06e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—atopic dermatitis	1.26e-06	4.84e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.2e-06	4.61e-06	CbGpPWpGaD
